Skip to content

Deferred registration: Fortrea code: 782153

Deferred registration: Fortrea code: 782153 Full scientific title to be added on or before the deferral expiry date

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN36988003
Enrollment
120
Registered
2026-07-21
Start date
2026-07-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The sponsor has requested a deferral. The full details will be added to the trial record on or before the deferral expiry date Other

Interventions

The sponsor has requested a deferral. The full details will be added to the trial record on or before the deferral expiry date

Sponsors

Roche (Switzerland)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
0 Years to 1 Years

Inclusion criteria

Inclusion criteria: The sponsor has requested a deferral. The full details will be added to the trial record on or before the deferral expiry date

Exclusion criteria

Exclusion criteria: The sponsor has requested a deferral. The full details will be added to the trial record on or before the deferral expiry date

Design outcomes

Primary

MeasureTime frame
[Outcome] measured using [measure] at [timepoint]. The sponsor has requested a deferral. The full details will be added to the trial record on or before the deferral expiry date

Countries

England, United Kingdom

Contacts

Public ContactSomasekhara Menakuru
som.menakuru@fortrea.com+44 113 394 5200

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Aug 10, 2026